I agree that extra cash would be a good thing but I would prefer to get it from a rich pharma paying hundreds of millions of dollars for a share in one of our programs than by getting tens of millions through issuing more shares. Both approaches provide cash, one produces a share price increase and the other keeps it stable at best. A big pharma partnership would also increase the credibility of Benitec and ddRNAi.
With regard to Tribetarna, this is a program that was supposed to go into the clinic in 2012. I am not saying that progress is not being made but, given the history, I think an update is well overdue. I also think we should know what has happened to the $3M, especially as the last announcement referred to a different CRO to the one to which the money was paid.
- Forums
- ASX - By Stock
- BLT
- re: announcement of adr ipo
re: announcement of adr ipo, page-14
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online